Scott Solomon, M.D.

Director, Clinical Trials Outcomes Center, Professor, Harvard Medical School
Brigham and Women’s Hospital

Poster(s):

• (M1330-05-28) Acoramidis Effect on All-Cause Mortality in Patients with p.V142I (V122I) Variant ATTR-CM: Findings from the ATTRibute-CM Study
  Monday, November 10, 2025

  1:30 PM - 2:30 PM CT